SUMMARY Central a-adrenergic mechanisms for cardiovascular regulation were studied by injecting phenylephrine into a recipient rat whose head was isolated from its body by cross perfusion with a donor rat. Blood pressure increases produced in the donor were accompanied by concurrent reduction of blood pressure and sympathetic nerve activity in the recipient rat's body. These effects were abolished when a-adrenergic receptors in the perfused head were blocked with pbeiitolamlne. By contrast, intracarotid injections of angiotensin increased blood pressure not only in donor but also in recipient rats. The magnitude of phenylephrine-induced vasodepression was significantly greater in spontaneously hypertensive rats (SHR) than in normotensive or DOCA-salt hypertensive ones. Distribution of radioactive microspheres indicated that carotid arterial blood went mainly to the cerebrum, midbrain, and hypotbalamus, with almost negligible amounts going to the lower brainstem. Collectively, our results suggest that centrally administered phenylephrine reduces sympathetic vasomotor tone and blood pressure by acting on a-adrenergic receptors located in supramedullary brain areas (possibly in the hypothalamus). In SHR, augmented vasodepressor responsiveness may be due to reduced brain levels of endogenous norepinephrine that could increase the «-adrenergic receptors available. ' * anterior hypothalamus, 6 or nucleus tractus solitarius;' and because both effects are abolished by phentolamine, they have been attributed to a-adrenergic receptors. Larger doses of norepinephrine injected either intracisternally 7 or into cerebral ventricles" elicit pressor effects (probably due to peripheral
T HE hypothesis that central adrenergic mech-
anisms contribute importantly to cardiovascular homeostasis
1 -2 is often tested by recording responses to centrally administered drugs in rats. Hypotension and bradycardia occur when norepinephrine is injected into the cerebral ventricles, 8 ' * anterior hypothalamus, 6 or nucleus tractus solitarius;' and because both effects are abolished by phentolamine, they have been attributed to a-adrenergic receptors. Larger doses of norepinephrine injected either intracisternally 7 or into cerebral ventricles" elicit pressor effects (probably due to peripheral leakage) that are stronger in spontaneously hypertensive rats (SHR) than in normotensive rats." Epinephrine injected into cerebral ventricles 10 or into the anterior hypothalamus 11 in SHR also lowers blood pressure and heart rate, but because these effects are antagonized by propranolol or metoprolol, they have been attributed to /3-adrenergic receptors. In general the information now available implies that unlike peripheral a-and /3-adrenergic receptors that produce opposite vascular effects, those in the brain produce similar effects; however, this supposition cannot be confirmed by using naturally occurring catecholamines like norepinephrine or epinephrine because they stimulate both types of receptors.
In an attempt to clarify underlying mechanisms, we tested intrahypothalamic injections of phenylephrine, a drug that stimulates a-adrenergic receptors almost exclusively. Assessment of data thus obtained was difficult because ensuing changes in blood pressure were small, prolonged, and irregular; accordingly, additional experiments were done to develop an isolated head preparation using a donor to perfuse the head of a recipient rat. Brain areas affected and leakage between the recipient rat's head and body were estimated from distribution of radioactivity following injection of tracer microspheres or m I-labeled albumin. In some experiments, spike potentials were
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recorded from abdominal sympathetic nerves; and to determine if the central adrenergic mechanisms thus revealed would be altered during hypertension, rats with spontaneous or deoxycorticosterone acetate (DOCA)-salt hypertension were also studied.
Methods
Four groups of 12-week-old Wistar rats were studied: normotensive, DOCA-salt hypertensive, and Kyoto-Wistar normotensive (KNR) and SHR. We purchased KNR and SHR, derived from the strain originally described by Okamoto and Aoki, u from Taconic Farms, Inc. (Germantown, NY); the others were outbred Wistar rats purchased from Charles River Breeding Laboratories (Wilmington, MA). Intrahypothalamic infusions were done on female rats weighing about 250 g, but since cross perfusion was best accomplished with large donor rats weighing 350 g or more, male rats were used routinely in all other experiments. To induce DOCA-salt hypertension, 3-week-old outbred Wistar rats were anesthetized with sodium pentobarbital (8 mg/100 g i.p.) and their left kidneys were removed; silicon rubber molds containing DOCA (20 mg/100 g body weight) were implanted subcutaneously 13 and 0.9% sodium chloride (isotonic saline) solution was substituted for drinking water. Eight weeks later, systolic pressures measured in these rats with the tail-cuff method" averaged 183 ± 6 mm Hg (p < 0.001, as compared with 119 ± 4 mm Hg for sham-operated controls 16 ).
Direct Hypothalamic Injections
Rats were anesthetized with urethane (100 mg/100 g i.p.) while a catheter was inserted into a femoral artery for recording blood pressure and heart rate. 18 A guide cannula (ga 23 stainless steel tubing) was implanted at stereotaxic coordinates: 6.6 anteroposterior, 1.2 lateral, and -2.0 dorsoventral for the anterior hypothalamus; and 4.8 anteroposterior, 0.8 lateral, and -2.6 dorsoventral for the posterior hypothalamus. Injections were given by inserting an injection cannula (ga 30 stainless steel tubing), connected to a 10 microliter syringe mounted on an infusion pump (Sage Instruments, Cambridge, MA), into the guide cannula. 17 The whole system was filled with the solution to be injected and each injection had a volume of 1 p\ given at a pump rate of 0.84 /xl/min. After each experiment, areas around the cannula tip were stained by localized injection of potassium ferrocyanide;
1 " and brain sections were then compared with those in a rat brain atlas. 19 At the anterior position, the cannula tip was located in the anterior hypothalamic area adjacent to the ventromedial hypothalamic nucleus, lateral hypothalamic area, median forebrain bundle, fornix, and paraventricular hypothalamic nucleus; at the posterior position, it was in the posterior hypothalamic nucleus immediately medial to the mamillothalamic tract and adjacent to the mamillotegmental tract, lateral hypothalamic area, dorsal premamillary nucleus, and fornix.
Intracarotid Injections in Isolated Head Preparations
Three rats, anesthetized with urethane, were used for each preparation: one supplied blood for priming extravascular connections while the others served as the donor and recipient respectively. Blood pressure and heart rate were routinely recorded from femoral catheters in all donor and recipient rats. Isolation of the recipient's head from its body was accomplished by connecting both jugular veins and common carotid arteries through a peristaltic pump (Rainin Instrument Co., Brighton, MA) to corresponding vessels of the donor rat ( fig. 1 ). As soon as one cannula had been inserted into a carotid artery in the recipient, it was temporarily connected to the femoral artery to allow continued supply of arterial blood to the head while the remaining carotid was being cannulated; hypoxia resulting from interruption of cerebral blood flow was thereby kept at a minimum. Perfusion pressure was recorded from a sidearm of the carotid circuit between the pump and the perfused head. Pump speed (2.5 to 5.2 ml/min) was always adjusted to keep carotid pressure in the recipient rat at the same level as femoral pressure. All catheters were made of silastic tubing with teflon tips. Total dead space (venous and arterial connections including the catheters) of 2 ml was filled with heparinized blood (500 U/100 g) from a third rat. In preliminary experiments in which a pump was not used, skin, skeletal muscles, and other soft tissues were either cut or ligated so that the recipient's head was connected to its body only by the vertebral column; however, many rats became dyspneic, hypotensive, and died; and since blood leakage into the body was substantially reduced when a pump was used, cervical soft tissues were left intact in all subsequent experiments.
DONOR
To allow recording of sympathetic nerve activity in some experiments, the abdominal plexus in the recipient's body was exposed and a bipolar stainless steel electrode (uninsulated tips 1 mm apart) was placed on the major nerve bundle accompanying the superior mesenteric artery immediately below the coeliac ganglion (hereafter referred to as the abdominal sympathetic nerve). Nerves and electrode tips were immersed in mineral oil to reduce tissue drying. Spike potentials for sympathetic nerve activity were recorded together with femoral arterial pressure on magnetic tape and later played back and analyzed as described by Takeda and Buflag. 20 Numbers of individual pulses per second were counted with a rate analyzer (Frederick Haer and Co., Brunswick, ME) and the output recorded as a histogram (see figs. 2 and 3), digitized through a computer interface, and printed by a programmed calculator (Monroe 1860, Litton Industries, Morristown, NJ).
Determination of Brain Areas Affected in the Perfused Head and Amount of Blood Leakage into the Body
Polystyrene tracer microspheres labeled with either strontium-85 or cerium-141 (3M Company, St. Paul, MN) were routinely injected into the perfused head after completion of most experiments to identify brain areas supplied by the carotid arteries. Microspheres 15 ± 3 n in size were suspended in 10% dextran and 0.05% Tween 80 by 10-minute use of a magnetic stirrer immediately before injection, and a standard dose of approximately 225,000 microspheres in 0.1 ml (containing 3 ^Ci) was injected. Bovine semm albumin labeled with iodine-125 3 ^Ci/5 fi\ (New England Nuclear, Boston, MA) was similarly injected to estimate leakage into the recipient rat's body. Blood for measuring radioactivity was collected for about 1 minute, after which the head was severed and the brain removed. Brains were cut into five sections representing the cerebrum, midbrain, hypothalamus, cerebellum, and lower brain stem; 21 these sections were weighed and their radioactivity measured by a gamma scintillation counter (Searle Analytic Inc., Des Plaines, IL). Fractional distribution of carotid blood flow was calculated by dividing the regional counts per minute of M Sr (or 141 Ce) by the total amount injected and then multiplying by 100. In seven outbred Wistar normotensive rats, a single bolus containing 3 jtCi of M1 Ce in 0.2 ml was injected directly into the left ventricle of the heart to determine total blood flow distribution in the brain.
Each recipient's body was dissolved by adding 50 g of potassium hydroxide pellets and boiling for 30 minutes; whole body (excluding the head) radioactivity was then measured from the resulting liquefied mixture. Percent of leakage from the perfused head into the body was calculated by dividing total counts per minute of U8 I in the liquefied (body) mixture by the amount of 124 I injected, and then multiplying by 100.
Statistics and Drugs Injected
Data, expressed as averages ± SEM, from the four groups of rats were compared by an analysis of variance; for F ratios significant at 5% or less, differences between pairs of means were examined by Duncan's multiple range test. 22 Results from only two groups were analyzed using t tests for comparing means of dependent or independent samples; differences at a 5% level (p < 0.05) or less were considered significant.
Drugs used were: phenylephrine hydrochloride (Neosynephrine), 0.1 to 1000 ng (salt)/rat, angiotensin amide (Hypertensin-CIBA), 0.5-2.0 ixg/rat, and phentolamine mesylate (Regitine), 50 Mg/rat. For perfused head experiments, drugs were diluted in isotonic saline solution and injected via the carotid circuit in a volume of 10 pi.
Results

Cardiovascular Effects of Intrahvpothalamic Microinjections of Phenylephrine
Injection of phenylephrine (10 fig) into the anterior or posterior hypothalamus in Kyoto-Wistar rats caused slight but long-lasting falls in mean femoral pressure whose magnitude tended to be larger in KNR than in SHR (table 1) . Heart rate changes were irregular and did not differ between groups. Doses 10 times larger (100 fig) had essentially the same effects, but larger doses of 0.5-1.0 mg produced prominent systemic pressor responses resembling those elicited by intravenous injection of 10 fig (table 1) . Effects of intrahypothalamic injections were difficult to interpret, not only because they were small, long-lasting, and unrelated to doses injected, but also because centrally induced vasodepression was masked by the increase in systemic blood pressure.
Phenylephrine-Induced Vasodepression in Cross-Perfused Head Preparations
Conditions optimal for recording cardiovascular responses to centrally administered drugs were established using seven pairs of outbred normotensive rats. Blood pressures in each rat pair were almost identical at the onset, but that in donor rats changed (decreased in four and increased in three) soon after vascular connections to the perfused head were opened; thus, the average baseline for mean femoral pressure (mm Hg ± SEM) of 90 ± 4 in donor rats was slightly lower (p > 0.1 < 0.5) than that of 97 ± 5 in recipient rats. Despite blood pressure fluctuations in donor rats, intracarotid injections of phenylephrine (0.1-10 /xg) given at 15-minute intervals consistently elevated femoral blood pressure in the donors while simultaneously lowering it in the recipients, with both effects being dose-dependent (table 2) . Larger doses (50 fig) elicited larger pressor responses in all donors, but corresponding vasodepression increased in only two of six recipients, and was either reduced or actually reversed to a pressor response in the others. •Average * SEM changes from five rats in each group with baselines of 80 ± 3 in Kyoto-Wistar normotensive rats (KNR) and 104 * 2 in spontaneously hypertensive rats (SHR) (p < 0.001) for mean femoral pressure, and 310 * 12 in KNR and 380 ± 9 in SHR (p < 0.001) for heart rate; none of the differences between groups are significant. •Average * SEM changes from baselines of 90 * 4 in donor and 97 * 5 in recipient rate; all differences between groups significant at 1%.
Spontaneous changes in perfusion pressure were subsequently reduced by interposing a peristaltic pump between circuits connecting donors and recipients.
Pump speed was set to deliver arterial inflow into the perfused head at a pressure approximating that in the femoral artery of the recipient rat. In seven rat pairs, blood pressure in donor rats fell as soon as the pump was turned on and then stabilized 10 to 15 minutes later at a level about 25 mm Hg lower than before; experiments began only after equilibration had occurred. Phenylephrine (5 jug) had the same effects as when a pump was not used: femoral blood pressure rose in the donors and fell in the recipients. Immediately preceding femoral vasodepression in recipient rats, carotid perfusion pressure increased while rate of sympathetic neural firing was reduced ( fig. 2B) .
To examine the possibility that responses to phenylephrine were caused by increased perfusion pressure, changes produced by accelerating pump speed were compared with those produced by phenylephrine. Average elevations in perfusion pressure produced by both procedures were almost equal: 39 ± 3 for accelerated pumping and 43 ± 4 for phenylephrine. And yet, femoral arterial pressure in recipient rats was unaffected by the increase in pump speed (-2 ± 2) but markedly lowered by phenylephrine (-18 ± 3; p < 0.005). Similarly, sympathetic neural firing was not appreciably affected by increases in pump speed ( fig. 2A ) but was reduced during phenylephrine-induced vasodepression ( fig. 2B) . Specificity of phenylephrine-induced vasodepression was determined by comparison with responses to intracarotid injections of angiotensin (0.5-2.0 /xg) in three preparations; angiotensin elevated carotid perfusion pressure consistently, but it also increased femoral pressures in both recipient and donor rats. Thus, although carotid perfusion pressure could be elevated by either accelerated pumping or injected angiotensin, neither procedure lowered femoral blood pressure in recipient rats.
Responses to phenylephrine were next recorded before and after a-adrenergic receptors were blocked by intracarotid injection of phentolamine, 50 ng. In four preparations, baselines for blood pressure were lowered while those for sympathetic neural firing were unchanged. Vasodepressor responses to phenylephrine were completely abolished for about 30 minutes (see fig. 3 for similar results in SHR); then they gradually reappeared and recovered fully an hour later. These results, therefore, suggest that centrally administered phenylephrine reduces blood pressure and sympathetic nerve activity by acting on a-adrenergic receptors in brain areas perfused by the carotid vascular bed.
Blood Flow Distribution in the Perfused Head
Brain areas perfused by the carotid arteries were identified by measuring regional distribution of radioactivity after injection of tracer microspheres. A stan- 
. Responses of a normotensive recipient rat to: A: mechanically induced increase in perfusion pressure and B: intracarotid injection of phenylephrine (5 iig). Start of stimulation in each panel is indicated by arrows. Tracings from top to bottom indicate: carotid perfusion pressure (mm Hg), phasic femoral pressure (mm Hg), rate of sympathetic neural firing (spikes/sec), and original analog signal of sympathetic nerve activity.
dard dose containing 225,000 microspheres in 0.1 ml had no appreciable cardiovascular effects. Carotid blood flow determined from fractional distribution of 86 Sr-labeled microspheres in perfused brains went mainly to the cerebrum, followed in descending order by the midbrain, hypothalamus, cerebellum, and lower brain stem (i.e., pons and medulla). Results expressed in terms of per gram tissue showed that the highest flow occurred in the hypothalamus, with less in the cerebrum and midbrain, and almost negligible amounts in the lower brain stem.
Normal distribution of cardiac output was estimated in seven intact rats by measuring radioactivity after left ventricular injection of ul Ce-labeled microspheres. By assuming that the cerebrum was always completely perfused regardless of route of injection, radioactivity in different areas was expressed as a percentage of cerebral perfusion rate to allow direct comparison of flow distribution in the carotid circuit with that following left ventricular injection (table 3) . Whereas relative distribution of radioactivity did not differ in the midbrain, amounts in the cerebellum and lower brain stem after left ventricular injection were much higher than those after intracarotid injection; this implies that blood flow to these areas normally comes from extracarotid sources (i.e., vertebral arteries). Conversely, because radioactivity in the hypothalamus after intracarotid injection was much higher than that after left ventricular injection, blood flow to the hypothalamus must normally come mainly from the carotid arteries.
Comparison of Phenylephrlne-Induced Vasodepresslon in Normotensive and Hypertensire Rats
To determine whether central a-adrenergic mechanisms become altered in hypertensive rats, responses to intracarotid injection of phenylephrine (5 g ) were recorded in the following rat pairs: 8 KNR, 7 SHR, and 5 DOCA-salt hypertensive. The DOCAsalt hypertensive recipients were paired with either outbred normotensive or DOCA-salt hypertensive donors. The baseline for mean femoral pressure in SHR recipients ( •fa 9 ± 9
•t 25 p value not significant < 0.005 < 0.005 < 0.005
•Averages * SEM expressed as percentage of cerebral blood flow.
hypertensives (t value of 4.17 significant at 5%); corresponding baselines for heart rate (/min) were 350 ± 15inKNR,421 ± 13 in SHR, 458 ± 10 in outbred normotensives, and 390 ± 9 in DOCA-salt hypertensives (F ratio of 12.98 significant at 1%). Increases in blood pressure produced by phenylephrine among donor rats were larger in SHR and outbred normotensives than in KNR and DOCA-salt hypertensives (using normotensive donors). A slight bradycardia ranging in magnitude from -1 1 to -19/min occurred in most recipient rats regardless of grouping. Clearly the most significant finding here was that magnitude of phenylephrine-induced vasodepression in SHR recipients was more pronounced than that in •Averages •*• SBM from eight Kyoto-Wistar normotensive rats (KNR), seven spontaneously hypertensive rats (SHR), six outbred normotensives (NT), and five DOCA-salt hypertensives (HT). For fi = 3 and fi = 25, F ratios of 4.86 or more are required for significance at 1% and of 2.99 or more for significance at 5%.
other groups ( fig. 4 and table 4) ; / values of 4.58 comparing SHR with KNR are significant at 1%, and of 3.35 and 3.31 for similar comparisons with outbred normotensives and DOCA-salt hypertensives are significant at 5%. Vasodepression in SHR recipients was also accompanied by reduced sympathetic neural firing, and both responses were abolished by intracarotid injection of phentolamine ( fig. 3) .
Carotid blood flow was uniformly distributed in all brain areas except the hypothalamus, which had disproportionately higher flows in SHR than in other rats. Actual values (flow distribution/g tissue) ( fig. 5 ) for the hypothalamus (F ratio of 7.88 significant at 1%) of 169.62 ± 17 in SHR were higher than those of 114.53 ± 1 1 for KNR (/ value of 3.21 significant at 5%), 120 ± 10 for outbred normotensives (t value of 2.68 not significant), or 78.05 ± 1 1 for DOCA-salt hypertensives (t value of 4.72 significant at 1%).
Because vascular separation between head and body of recipient rats was incomplete (i.e., vascular connections through cervical soft tissues and vertebral column were patent), magnitude of leakage was estimated from the percentage of 1U I found in the body after injection into the perfused head. Leakage was generally higher in KNR (18.7 ± 1%) and SHR (15.42 ± 2%) than in either outbred normotensives (11.89 ± 2 % ) or DOCA-salt hypertensives (9.46 ± 1%). The F ratio of 5.78 is significant at 1%, but of the different comparisons between pairs of means, only the t value for KNR versus DOCA-salt hypertensives (3.80) is significant at 5%. In general, therefore, leakage from head to body was less than 20% so that if distribution of phenylephrine parallels that of the microspheres, for every 5 ^1 of phenylephrine injected, less than 1 ng would reach vascular beds in the recipient's body.
Discussion
Central localization by drug injection into a recipient animal, whose head is connected to its body solely through the spinal cord, was first described in dogs by Heymans been used in rats until now, but the underlying principle is still that neurally mediated effects can be separated from others exerted on the cardiovascular system. Despite several modifications (i.e., a peristaltic pump was used to maintain blood flow to and from the head constant; cervical tissues and buffer nerves were left intact; and vertebral arteries were not occluded), leakage from the head into the body was less than 20%, and our donor-recipient pairs usually remained viable. Vascular isolation of the head was not exactly the same; yet our results agree with those described by Taylor and Page 24 in that centrally injected adrenergic agonists, which normally produce pressor effects, consistently produced vasodepression instead.
How phenylephrine injected into the head caused blood pressure in the body of a recipient rat to fall, or why vasodepression thus induced lasted twice as long as the pressor response to intravenous injection, is uncertain. Because most vessels connecting the head and body had been cut, it seems reasonable to assume that systemic effects were mediated neurally through the spinal cord and sympathetic nerves. Although the blood-brain barrier is generally believed to prevent entry of most amines from the blood into the brain, 88 the induction of systemic vasodepression here implies that phenylephrine did cross the barrier at some point. Presumably this happens at brain regions like the median eminence or area postrema where capillaries with fenestrated endothelia provide specific sites for transferring solutes regardless of size or lipid solubility. 28 Our results suggest that after crossing the blood-brain barrier, phenylephrine acted on aadrenergic receptors in the hypothalamus to reduce efferent sympathetic vasomotor tone and thereby lower blood pressure. The brain receptors involved were probably a-adrenergic because they were stimulated by phenylephrine and because resulting effects were abolished by phentolamine. Furthermore, regional distribution of carotid blood flow indicated that exposure to phenylephrine was highest in supramedullary brain areas, including the hypothalamus; and mapping done with microinjections has shown that the anterior preoptic region located close to the median eminence is among the areas most responsive to norepinephrine. 6 Intrahypothalamic infusion appears unreliable for studying drugs acting on the brain because effective stimulation depends on delivery of highly concentrated solutions in volumes that must not exceed 1 n\." Aside from the fact that direct injections may cause neural damage, accurate infusion of such minute amounts is technically difficult, and physical characteristics of the chemical (i.e., rate of dissolution, metabolic degradation, and extent of tissue dispersion) injected determine the duration of ensuing effects. Although our standard 10 ng dose (about 4 nmol) for phenylephrine was smaller than that used by Struyker Boudier et al. (70 nmol), 6 it sufficed to elicit pressor effects upon intravenous injection; and with infusion of larger doses into the hypothalamus, we obtained pressor responses just as they did. Thus, any centrally induced vasodepression would have been obscured by systemic pressor effects produced by phenylephrine absorbed from the site of infusion.
Decreases in sympathetic activity and blood pressure resembling those shown here are also produced by clonidine, which presumably acts on an inhibitory a-adrenergic system in the nucleus tractus solitarius to activate baroreceptor reflexes." If it is assumed that phenylephrine acts mainly on the hypothalamus, then our results could mean that the forementioned inhibitory system extends above the medulla. By contrast, the existence of an excitatory aadrenergic system in the hypothalamus has been proposed based on drug-induced changes in pressor responsiveness to electrical stimulation of the posterior hypothalamus (i.e., inhibition by aadrenergic blockade with tolazoline or piperoxan, and enhancement upon reduction of norepinephrine reuptake with desipramine). 3 But although these studies seem linked to ours by common involvement of central a-adrenergic mechanisms, further comparisons cannot be made because of obvious differences not only in methods of stimulation employed, but aho in brain areas affected.
Why responsiveness to phenylephrine-induced vasodepression was augmented selectively in SHR is conjectural. Although blood-brain barrier dysfunction has been reported after abrupt pressure elevations in renal hypertensive rats, 28 or when carotid arterial pressure is increased beyond 200 mm Hg, 35 this would not account for our results, because the blood pressure elevation in SHR was not very high and was in fact lower than that in DOCA-salt hypertensive rats (table  4) . A possible explanation is that with increased flow to the hypothalamus (see fig. 5 ), amounts of phenylephrine delivered to a-adrenergic receptors there were higher in SHR than in other rats. Alternatively, a derangement of catecholamine metabolism in the hypothalamus could be involved. Based on the diminished hypothalamic levels of norepinephrine first reported by Yamori et al." and recently confirmed by Saavedra et al., 30 it can be argued that reduced levels of endogenous norepinephrine would leave more aadrenergic receptors available for phenylephrine, such that ensuing vasodepression would therefore become more pronounced.
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hypertensive rats.
Augmentation of centrally induced alpha-adrenergic vasodepression in spontaneously
